suxamethonium chloride aguettant 10 mg/ ml
laboratoire aguettant - suksametoniumkloriddihydrat - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 10 mg/ ml
byooviz
samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - Øyemidler - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - Øyemidler - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - Øyemidler - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
omidria
rayner surgical (ireland) limited - ketorolac, phenylephrine - lens implantation, intraocular; pain, postoperative - Øyemidler - omidria er indisert hos voksne for vedlikehold av intraoperativ mydriasis, forebygging av intraoperativ miose og reduksjon av akutt postoperativ okulær smerte i intraokulær linseutskiftingskirurgi.
thymoglobuline 25 mg
sanofi b.v. - immunglobulin anti-human thymocytt (kanin) - pulver til infusjonsvæske, oppløsning - 25 mg
clindabactin 440 mg
dechra veterinary products (1) - klindamycinhydroklorid - tyggetablett - 440 mg
clindabactin 55 mg
dechra veterinary products (1) - klindamycinhydroklorid - tyggetablett - 55 mg
clindabactin 220 mg
dechra veterinary products (1) - klindamycinhydroklorid - tyggetablett - 220 mg
givix vet 88 mg
ceva santé animale - klindamycinhydroklorid - tyggetablett - 88 mg